Article
Differences in biomarkers and molecular pathways according to age for patients with HFrEF
17 Sept 2020
Abstract excerpt
AIMS: Elderly patients with heart failure with reduced ejection fraction (HFrEF) have worse prognosis and less often receive guideline-recommended therapies. We aim to better understand the underlying pathophysiological processes associated with ageing in HFrEF potentially leading to targeted therapies in this vulnerable population. METHODS AND RESULTS: From a panel of 363 cardiovascular biomarkers available in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
